On step two of the Alice/Mayo test, the Court found as follows:
VANDA PHARMACEUTICALS INC. and A VENTISUB LLC,. Plaintiffs, v. ... of the '
610 Patent; (3) Roxane's proposed products do not contributorily infringe the as~
erted claims ..... Laboratory tests are available to identify CYP2D6 PMs." § 12.3.
Aug 25, 2016 ... The suit is Vanda Pharmaceuticals Inc. et al. v. Roxane Laboratories Inc., case
numbers 1:13-cv-01973 and 1:14-cv-00757, in the U.S. District ...
Jun 16, 2014 ... Plaintiff Vanda Pharmaceuticals Inc. (“Vanda”) for its Complaint against.
Defendant Roxane Laboratories, Inc. (“Roxane”) alleges as follows: ... Corp. v.
Roxane. Labs., Inc., 13-cv-1973 (D. Del.); Eisai Co. v. Roxane Labs., Inc.
Vanda Pharmaceuticals Inc. et al v. Roxane Laboratories Inc. 1:13-cv-01973;
Filed: 11/25/2013; Closed: 08/25/2016; Latest Docket Entry: 09/26/2016; PACER.
Aug 26, 2016 ... Vanda Pharmaceuticals fends off patent challenge from generic competitor ...
Ohio-based generics maker Roxane Laboratories Inc. sought ...
Sep 6, 2016 ... In Vanda Pharmaceuticals Inc. v. Roxane Labs., Inc., Judge Sleet of the U.S.
District Court for the District of Delaware upheld the patent ...
Sep 1, 2016 ... Vanda Pharmaceuticals Inc. v. Roxane Laboratories, Inc., C.A. Nos. 13-1973, 14-
757-GMS (D. Del. Aug. 25, 2016). Notably, Judge Sleet found ...
Nov 28, 2016 ... Inc. The case involved Roxane's U.S. Patent No. 8563032 ... when these efforts
prove inadequate, in Roxane Labs., Inc. v. Camber Pharm. Inc.
Mar 20, 2016 ... Roxane Laboratories Inc. 1:15-cv-00919; filed October 13, 2015 in the District
Court of Delaware Vanda Pharmaceuticals Inc. v. Inventia ...